India is preparing to launch the dot-Bharat domain name in Hindi in May with the aim of bridging the digital divide in the country India is preparing to launch the dot-Bharat domain name in Hindi in May with the aim of bridging the digital divide in the country. The move will enable organizations and individuals to register their website addresses in Hindi—and later more local languages—making them more accessible to a...
More »SEARCH RESULT
EU stamp for Darjeeling Tea by Vivek Chhetri
The European Commission has registered Darjeeling Tea as a Protected Geographic Indication (PGI) product — the first commodity from India to get such a tag. The status implies that the brew produced only in Darjeeling can be sold as Darjeeling Tea in the European Union countries. But a section of blenders, who at present pass off brew with a certain percentage of Darjeeling brew as Darjeeling Tea, have been given a...
More »Medicines: For Saving Life or For Superprofits? by Bharat Dogra
Will patent rights be used only for ensuring the legitimate interests of pharmaceutical companies, or will these be used in an exaggerated and unjust way to deprive patients of their right to life? This crucial question, which has been debated time and again in the context of the significant case of Glivec, an anti-cancer drug, has now reached a critical stage. It may be pointed out here that as early as...
More »Affordable medicine
-The Business Standard It appears a committee headed by Planning Commission member Arun Maira examining the case for continued unrestricted foreign direct investment (FDI) in the pharmaceutical industry has opted to oppose the move to change the present regime. The only concession it is willing to make to the health and commerce ministries’ demand that approval of such investment be routed through the Foreign Investment Promotion Board is to ask for...
More »Bitter pill for Big Pharma by Bhupesh Bhandari
A committee headed by Planning Commission member Arun Maira, the former head of The Boston Consulting Group in India, wants all acquisitions of Indian pharmaceutical companies by foreigners to be scanned by the Competition Commission of India or CCI. The report will now be sent to Prime Minister Manmohan Singh and Planning Commission Deputy Chairman Montek Singh Ahluwalia. Prime Minister Singh is expected to take a final view on the...
More »